Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood–brain barrier disruption in rabbits

[1]  R. Rennert,et al.  Minimally invasive treatment of intracerebral hemorrhage , 2015, Expert review of neurotherapeutics.

[2]  Z. Yang,et al.  Treatment of Supratentorial Spontaneous Intracerebral Hemorrhage Using Image-Guided Minimally Invasive Surgery: Initial Experiences of a Flat Detector CT–Based Puncture Planning and Navigation System in the Angiographic Suite , 2014, American Journal of Neuroradiology.

[3]  L. Bian,et al.  A New Choice of Minimally Invasive Surgery for Intracerebral Hemorrhage in the Striatocapsular Regions Based on Computed Tomography Scans , 2014, The Journal of craniofacial surgery.

[4]  Qing-Wu Yang,et al.  Inflammation in intracerebral hemorrhage: From mechanisms to clinical translation , 2014, Progress in Neurobiology.

[5]  I. Awad,et al.  Spontaneous Intracerebral and Intraventricular Hemorrhage: Advances in Minimally Invasive Surgery and Thrombolytic Evacuation, and Lessons Learned in Recent Trials. , 2014, Neurosurgery.

[6]  I. Awad,et al.  Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials. , 2014, Neurosurgery.

[7]  Guofeng Wu,et al.  Early stage minimally invasive procedures reduce perihematomal MMP-9 and blood–brain barrier disruption in a rabbit model of intracerebral hemorrhage , 2013, Neurological research.

[8]  D. Hanley,et al.  Minimally Invasive Surgery Plus Recombinant Tissue-type Plasminogen Activator for Intracerebral Hemorrhage Evacuation Decreases Perihematomal Edema , 2013, Stroke.

[9]  H. Nawashiro,et al.  Decompressive craniectomy with hematoma evacuation for large hemispheric hypertensive intracerebral hemorrhage. , 2013, Acta neurochirurgica. Supplement.

[10]  Ming Liu,et al.  Minimally Invasive Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage: A Meta-Analysis of Randomized Controlled Trials , 2012, Stroke.

[11]  T. Steiner,et al.  Matrix Metalloproteinases in Human Spontaneous Intracerebral Hemorrhage: An Update , 2012, Cerebrovascular Diseases.

[12]  R. Keep,et al.  Intracerebral haemorrhage: mechanisms of injury and therapeutic targets , 2012, The Lancet Neurology.

[13]  Guofeng Wu,et al.  The pathophysiological time window study of performing minimally invasive procedures for the intracerebral hematoma evacuation in rabbit , 2012, Brain Research.

[14]  J. Broderick,et al.  Individual Patient Data Subgroup Meta-Analysis of Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage , 2012, Stroke.

[15]  Z. Hong,et al.  Effects of minimally invasive procedures for removal of intracranial hematoma on matrix metalloproteinase expression and blood-brain barrier permeability in perihematomal brain tissues , 2011, Neurological research.

[16]  Z. Hong,et al.  Minimally Invasive Procedures for Evacuation of Intracerebral Hemorrhage Reduces Perihematomal Glutamate Content, Blood–Brain Barrier Permeability and Brain Edema in Rabbits , 2011, Neurocritical care.

[17]  Brian Y. Hwang,et al.  Advances in Neuroprotective Strategies: Potential Therapies for Intracerebral Hemorrhage , 2010, Cerebrovascular Diseases.

[18]  Rita Ouellet-Hellstrom,et al.  Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. , 2010, JAMA.

[19]  E. Fainardi,et al.  Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage. , 2010, Acta neurochirurgica. Supplement.

[20]  Lixiao Xie,et al.  [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome]. , 2009, Zhonghua xin xue guan bing za zhi.

[21]  M. Arababadi,et al.  Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat , 2009, Brain Research.

[22]  A. Carpentier,et al.  Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients , 2009, Diabetes & vascular disease research.

[23]  J. Grotta,et al.  Hematoma resolution as a therapeutic target: the role of microglia/macrophages. , 2009, Stroke.

[24]  A. Demchuk,et al.  Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. , 2009, Brain : a journal of neurology.

[25]  V. Yong,et al.  Matrix metalloproteinases in intracerebral hemorrhage , 2008, Neurological research.

[26]  Jeffry Alger,et al.  Image-guided endoscopic evacuation of spontaneous intracerebral hemorrhage. , 2008, Surgical neurology.

[27]  H. Lei,et al.  [Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients]. , 2008, Zhonghua yi xue za zhi.

[28]  D. Hanley,et al.  Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. , 2008, Acta neurochirurgica. Supplement.

[29]  A. Shabanzadeh,et al.  Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. , 2007, Basic & clinical pharmacology & toxicology.

[30]  J. Grotta,et al.  Hematoma resolution as a target for intracerebral hemorrhage treatment: Role for peroxisome proliferator‐activated receptor γ in microglia/macrophages , 2007, Annals of neurology.

[31]  Chad M. Miller,et al.  Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduced levels of extracellular cerebral glutamate and unchanged lactate pyruvate ratios , 2007, Neurocritical care.

[32]  N. Kawai,et al.  Expression of matrix metalloproteinase-9 in thrombin-induced brain edema formation in rats. , 2006, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[33]  John H. Zhang,et al.  MMP-9 Deficiency Enhances Collagenase-Induced Intracerebral Hemorrhage and Brain Injury in Mutant Mice , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  A. K. Banerji,et al.  Neuroendoscope-assisted evacuation of large intracerebral hematomas: introduction of a new, minimally invasive technique. Preliminary report. , 2004, Neurosurgical focus.

[35]  Ruth Thiex M. D.,et al.  Frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral hemorrhage , 2004, Journal of Neurology.

[36]  M. Hetzel,et al.  Inhibition of MMP-9 expression by PPARγ activators in human bronchial epithelial cells , 2003, Thorax.

[37]  J. Lodder,et al.  Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator: A Multicenter Randomized Controlled Trial (SICHPA) , 2003, Stroke.

[38]  Minimally invasive therapy for intracerebral hematomas. , 2002, Neurosurgery clinics of North America.

[39]  A. Mendelow,et al.  Surgery in Intracerebral Hemorrhage: The Uncertainty Continues , 2000, Stroke.

[40]  M. Devous,et al.  Microfibrillar collagen model of canine cerebral infarction. , 1989, Stroke.

[41]  A. Givré.  [Surgery of intracerebral hemorrhage]. , 1959, El Dia medico.